The Technical Analyst
Select Language :
PureTech Health plc [PRTC]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

PureTech Health plc Price, Forecast, Insider, Ratings, Fundamentals & Signals

PureTech Health plc is listed at the  Exchange

-1.18% $28.50

America/New_York / 28 mar 2024 @ 16:00


PureTech Health plc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 770.10 mill
EPS: -1.700
P/E: -16.76
Earnings Date: Apr 25, 2024
SharesOutstanding: 27.02 mill
Avg Daily Volume: 0.0037 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Neutral
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
4/212/223/224/221/232/23
Revenuen/an/an/a
Gr.Profitn/an/an/a
Ebitn/an/an/a
Asset n/an/an/an/a
Debtn/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -16.76 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-2.85x
Company: PE -16.76 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$3.14
(-88.98%) $-25.36
Date: 2024-03-29
Expected Trading Range (DAY)

$ 27.21 - 29.79

( +/- 4.53%)
ATR Model: 14 days

Forecast: 16:00 - $28.50

Live Trading Signals (every 1 min)

Forecast 1: 15:04 - $28.51
Forecast 2: 15:54 - $28.46
Forecast 3: 16:00 - $28.50
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
Volume Signals
Price $28.50 (-1.18% )
Volume 0.0051 mill
Avg. Vol. 0.0037 mill
% of Avg. Vol 137.97 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for PureTech Health plc

Last 12 Months

Last 12 months chart data with high, low, open and close for PureTech Health plc

RSI

Last 10 Buy & Sell Signals For PRTC

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            PureTech Health plc

PRTC

PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and psychosis in Alzheimer's disease; a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions; an immunomodulation platform to treat chronic and acute inflammatory disorders; oral therapies based on defined consortia of bacteria is isolated from the human microbiome; and therapies to treat cognitive dysfunction associated with depression, multiple sclerosis, post COVID and ICU, and cancer related conditions. It also provides hematopoietic stem cell based therapies for patients with blood cancer; a voice-based technology platform to detect voice changes linked to health conditions; and a technology platform for the oral delivery of biologics, vaccines, and other drugs. In addition, the company is developing LYT-100 to treat lymphedema, and other lymphatic flow disorders; LYT-200, a IgG4 monoclonal antibody to target galectin-9; LYT-210 to treat solid tumors; Glyph, a synthetic lymphatic targeting chemistry platform; Orasome technology to enable the oral administration of macromolecule therapeutic payloads; meningeal lymphatics platform to treat Alzheimer's and Parkinson's diseases; and Alivio technology platform for inflammation-targeted disease immunomodulation. PureTech Health plc has collaboration and license agreements with Boehringer Ingelheim International GMBH; Eli Lilly and Company; Imbrium Therapeutics L.P.; and Shionogi & Co., Ltd. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Last 10 Buy Signals

Date Signal @
AVAXUSDMar 29 - 05:33$53.44
CGOUSDMar 29 - 05:2971.87
CVCUSDMar 29 - 05:31$0.206
RIOUSDMar 29 - 05:292.43
TAOUSDMar 29 - 05:29531.83
PROPCUSDMar 29 - 05:254.70
DUSKUSDMar 29 - 05:230.575
ETHUPUSDMar 29 - 05:2134.38
EGXUSDMar 29 - 05:20200.18
BONDUSDMar 29 - 05:224.87

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.